These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 932174)

  • 1. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.
    Crockett SE; Cataland S; Falko JM; Mazzaferri EL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1098-103. PubMed ID: 932174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.
    Falko JM; Crockett SE; Cataland S; Mazzaferri EL
    J Clin Endocrinol Metab; 1975 Aug; 41(2):260-5. PubMed ID: 1159045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of gastric inhibitory polypeptide and insulin secretion.
    Williams RH; May JM; Biesbroeck JB
    Metabolism; 1981 Jan; 30(1):36-40. PubMed ID: 7007799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F; Ebert R; Creutzfeldt W
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
    Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG
    Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Hayes TM
    Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W; Talaulicar M; Ebert R; Willms B
    Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog.
    Pederson RA; Schubert HE; Brown JC
    Diabetes; 1975 Dec; 24(12):1050-6. PubMed ID: 1193309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide.
    Creutzfeldt W; Ebert R; Finke U; Konturek SJ; Kwiecień N; Radecki T
    J Physiol; 1983 Jan; 334():91-101. PubMed ID: 6864570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R; Arnold R; Creutzfeldt W
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.